XML 48 R33.htm IDEA: XBRL DOCUMENT v2.3.0.15
Acquisitions (Pro Forma Financial Information Related To Additional Borrowings) (Details) (Bioniche Pharma Holdings Limited [Member], USD $)
In Thousands, except Per Share data
3 Months Ended9 Months Ended
Sep. 30, 2010
Sep. 30, 2010
Bioniche Pharma Holdings Limited [Member]
  
Total revenues$ 1,386,730$ 4,127,302
Net earnings attributable to Mylan Inc. before preferred dividends135,602307,306
Preferred dividends34,759104,276
Net earnings attributable to Mylan Inc. common shareholders$ 100,843$ 203,030
Earnings per common share attributable to Mylan Inc. common shareholders:  
Basic$ 0.33$ 0.66
Diluted$ 0.31$ 0.65
Weighted average common shares outstanding:  
Basic309,446308,470
Diluted437,921313,014